These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1932271)

  • 1. Chiral drugs: an industrial analytical perspective.
    Wozniak TJ; Bopp RJ; Jensen EC
    J Pharm Biomed Anal; 1991; 9(5):363-82. PubMed ID: 1932271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chiral drugs: the FDA perspective on manufacturing and control.
    De Camp WH
    J Pharm Biomed Anal; 1993; 11(11-12):1167-72. PubMed ID: 8123731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The market of chiral drugs: Chiral switches versus de novo enantiomerically pure compounds.
    Calcaterra A; D'Acquarica I
    J Pharm Biomed Anal; 2018 Jan; 147():323-340. PubMed ID: 28942107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enantiomeric separation and determination of absolute stereochemistry of asymmetric molecules in drug discovery: building chiral technology toolboxes.
    McConnell O; Bach A; Balibar C; Byrne N; Cai Y; Carter G; Chlenov M; Di L; Fan K; Goljer I; He Y; Herold D; Kagan M; Kerns E; Koehn F; Kraml C; Marathias V; Marquez B; McDonald L; Nogle L; Petucci C; Schlingmann G; Tawa G; Tischler M; Williamson RT; Sutherland A; Watts W; Young M; Zhang MY; Zhang Y; Zhou D; Ho D
    Chirality; 2007 Sep; 19(9):658-82. PubMed ID: 17390370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Separation of chiral pharmaceutical drugs by chromatographic and electrophoretic techniques].
    Morin P
    Ann Pharm Fr; 2009 Jul; 67(4):241-50. PubMed ID: 19596097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chiral chromatographic resolution of antiepileptic drugs and their metabolites: a challenge from the optimization to the application.
    Fortuna A; Alves G; Falcão A
    Biomed Chromatogr; 2014 Jan; 28(1):27-58. PubMed ID: 23946142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enantioselective chromatography in drug discovery.
    Zhang Y; Wu DR; Wang-Iverson DB; Tymiak AA
    Drug Discov Today; 2005 Apr; 10(8):571-7. PubMed ID: 15837600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances, challenges and perspectives in enantioselective release.
    Song L; Pan M; Zhao R; Deng J; Wu Y
    J Control Release; 2020 Aug; 324():156-171. PubMed ID: 32422210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparative Scale Resolution of Enantiomers Enables Accelerated Drug Discovery and Development.
    Leek H; Andersson S
    Molecules; 2017 Jan; 22(1):. PubMed ID: 28106796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enantiomeric purity of synthetic therapeutic peptides: A review.
    Badgujar D; Paritala ST; Matre S; Sharma N
    Chirality; 2024 Mar; 36(3):. PubMed ID: 38448043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advantages of electronic circular dichroism detection for the stereochemical analysis and characterization of drugs and natural products by liquid chromatography.
    Bertucci C; Tedesco D
    J Chromatogr A; 2012 Dec; 1269():69-81. PubMed ID: 23040981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The discovery process in the pharmaceutical industry].
    Scatton B
    J Soc Biol; 2009; 203(3):249-69. PubMed ID: 19833071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Analytical Methodologies for the Determination of Omeprazole and/or Its Active Isomer Esomeprazole in Different Matrices: A Critical Review.
    El-Kimary EI; Ragab MAA
    Crit Rev Anal Chem; 2022; 52(1):106-130. PubMed ID: 32683883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A validated chiral LC method for the enantiomeric separation of Zolmitriptan key intermediate, ZTR-5.
    Srinivasu MK; Rao BM; Sridhar G; Chandrasekhar KB; Kumar PR
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):796-800. PubMed ID: 15941641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How incoming guidelines on chiral drugs could impact on the international scenery of drug development.IUPAC.
    Marzo A
    Boll Chim Farm; 1993 Sep; 132(8):267-71. PubMed ID: 8217069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chiral purity assay for Flindokalner using tandem mass spectrometry: method development, validation, and benchmarking.
    Young BL; Cooks RG; Madden MC; Bair M; Jia J; Aubry AF; Miller SA
    J Pharm Biomed Anal; 2007 Apr; 43(5):1602-8. PubMed ID: 17298872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Industrial biotransformations in the synthesis of building blocks leading to enantiopure drugs.
    Muñoz Solano D; Hoyos P; Hernáiz MJ; Alcántara AR; Sánchez-Montero JM
    Bioresour Technol; 2012 Jul; 115():196-207. PubMed ID: 22230779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and utilization of biocatalysts for chiral synthesis: an overview of Chinese scientists' research and development.
    Yu HL; Xu JH; Lu WY; Lin GQ
    Adv Biochem Eng Biotechnol; 2009; 113():1-31. PubMed ID: 19623477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chiral discrimination and enantioselective analysis of drugs: an overview.
    Izake EL
    J Pharm Sci; 2007 Jul; 96(7):1659-76. PubMed ID: 17221858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of reversible interconversion in comprehensive two-dimensional gas chromatography using enantioselective columns in first and second dimensions.
    Kröger S; Wong YF; Chin ST; Grant J; Lupton D; Marriott PJ
    J Chromatogr A; 2015 Jul; 1404():104-14. PubMed ID: 26058951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.